Dalton Announces Collaboration Developing a Promising Broad Spectrum…
Dalton signs manufacturing agreement for a potent antiviral agent that has shown to be effective in animal studies against avian influenza virus, ebola and alphavirus infections
(PRWeb April 24, 2012)
Read the full story at http://www.prweb.com/releases/Dalton/antiviral-agent/prweb9354323.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.